Alvotech ehf., of Iceland, and an independent sister company of U.S. pharmaceutical firm Alvogen Group Inc., recently joined hands with China's Changchun High & New Technology Industries Group Inc. to develop, manufacture and commercialize Alvotech's biosimilars in the Asian country. The collaboration will see a new joint venture with manufacturing capabilities in China's Jilin province, which will be equally funded by both companies.